Dr Daniel Chan Boon Yeow

In 2000, Dr. Chan earned his medical degree with honours from the National University of Singapore (NUS) School of Medicine. He completed additional internal medicine training to earn the Member of the Royal College of Physicians (UK) designation in 2004. His training as a medical oncology expert was completed at Singapore's National University Cancer Institute. In October 2014, he became the first person in South Asia to use the immunotherapy drug Pembrolizumab, a PD-1 inhibitor. With a particular clinical interest in breast cancer, colon cancer, lung cancer, lymphoma, and sarcoma, Dr. Daniel Chan accepts referrals for all cancer types.

Qualification

• MBBS (Hons)
• MRCP (UK)
• FAMS (Medical Oncology)
• FRCP (UK)